AWPCX | RERBX | AWPCX / RERBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 22 years | - |
Gain YTD | 8.850 | 7.570 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.01B | 139B | 1% |
Annual Yield % from dividends | 0.00 | 1.00 | - |
Returns for 1 year | 19.93 | 15.44 | 129% |
Returns for 3 years | -18.28 | -16.20 | 113% |
Returns for 5 years | 20.01 | 12.75 | 157% |
Returns for 10 years | 10.78 | 20.62 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THD | 68.09 | 0.38 | +0.56% |
iShares MSCI Thailand ETF | |||
GLDI | 154.62 | 0.69 | +0.45% |
Credit Suisse X-Links Gold Cov Call ETN | |||
CDC | 64.44 | 0.16 | +0.25% |
VictoryShares US EQ Inc Enh Vol Wtd ETF | |||
BTEC | 39.49 | N/A | N/A |
Principal Healthcare Innovators ETF | |||
SPHQ | 67.20 | -0.11 | -0.16% |
Invesco S&P 500® Quality ETF |